
    
      A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Compare the Safety and
      Pharmacokinetics of CKD-390 Tablet (Tenofovir Disoproxil Aspartate) With VireadÂ® Tablet
      (Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers
    
  